The filler is injected into the upper layers of the dermis. It is developed for the treatment of superficial lines, including crow’s feet, glabellar lines, and neck wrinkles for a flawless result.

Regenovue is a dermal hyaluronic acid- (HA)-based filler with the 100% cross-linked structure. Innovative patented technology of HA cross-linking is used in the production of Regenovue. The product has outstanding purity, which means a minimum concentration of BDDE-derived by-products. Regenovue fillers are characterized by high elasticity and viscosity thus providing their even distribution and a long-lasting aesthetic effect. Compact structure of the gel guarantees a constant injection pressure (uniform injection rate), which makes the procedure as comfortable and easy as possible both for the patient and the specialist.

Strengths of Regenovue:

• one of the lowest levels of residual BDDE among dermal fillers (<0.0015 IU/mg)
• long-lasting esthetic effect due to the high viscosity and elasticity of the filler
• painless and injury-free injection due to the finely-divided gel structure and the presence of lidocaine in the composition
• dense monophasic structure of the gel ensures its uniform distribution in the subcutaneous layers
• natural-looking effect
• the products contain HA of non-animal origin
• provides elasticity and moisture to the skin

Treatment areas:

• periorbital wrinkles (crow’s feet)
• glabellar lines
• perioral lines
• neck lines
• forehead lines

Features of Regenovue Fine Plus

• Ingredients: HA 24mg/ml, Lidocaine 0.3%
• Injecting area: Lower subcutaneous
• Contents: 1x 1.1ml, 2 x 30G needles
• Duration: 8 – 12 months
• Shelf Life: 24 months
• With lidocaine: Yes